Anadolu Medical Center
| Turchia | Austria | Spagna | |
| Terapia protonica per il cancro alla prostata | da $30,000 | da $80,000 | da $70,000 |
| Terapia protonica per il cancro al seno | da $30,000 | da $55,000 | da $85,000 |
| Terapia con protoni | da $70,000 | da $80,000 | da $25,061 |
| Resezione ossea | da $8,000 | da $25,000 | da $20,000 |
| Chemioterapia per carcinoma mammario | da $1,200 | da $15,000 | da $3,500 |
Il medico è un oncologo medico turco altamente esperto, specializzato in sarcoma, linfoma, cancro al pancreas, polmone e seno. Con oltre 20 anni di esperienza, il medico si concentra sulla biologia dei tumori, l'immunologia dei tumori, l'immunoterapia del cancro e le terapie mirate. Dal 2019, il medico lavora come oncologo medico presso il Centro Medico Anadolu e ha precedentemente ricoperto ruoli di leadership presso la Facoltà di Medicina dell'Università Okan di Istanbul e l'Ospedale di Formazione GATA Haydarpaşa. Il medico è autore di oltre 40 pubblicazioni nella ricerca sul cancro ed è membro dell'Associazione Turca di Oncologia Medica e della Società Europea di Testa e Collo.<\/p>
Il Dr. Mustafa Solak è specializzato nel trattamento di vari tipi di cancro, inclusi casi rari come il condrosarcoma, presso l'Hisar Hospital Intercontinental.
Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.
Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.
Dr. Mehmet Taner Ozdemir is an orthopedist and bone tumor specialist at Anadolu Medical Center. He completed training at the Hospital for Special Surgery in New York. This facility is a top-ranked center for orthopedics in the United States. Dr. Ozdemir focuses on orthopedic oncology and complex trauma surgery.
The best treatment for chondrosarcoma in Turkey is wide surgical resection performed by an orthopedic oncologist. Specialized centers like Anadolu Medical Center use multidisciplinary teams to ensure clear margins. Advanced diagnostics including PET-CT and bone scintigraphy are essential for precise tumor staging and surgical planning.
Bookimed Expert Insight: Bookimed data shows Turkey is a top global destination for oncology, serving over 12,000 patients annually. While many clinics have JCI accreditation, look for specialists with international fellowships. For example, Dr. Mehmet Taner Ozdemir trained at the Hospital for Special Surgery in New York. This specific orthopedic oncology background is more critical for chondrosarcoma than general surgical experience.
Patient Consensus: Patients emphasize that while results are excellent, high-tier care at centers like Anadolu can be expensive. They note it is vital to ensure your surgeon specializes specifically in bone sarcomas rather than general orthopedics.
Turkish surgeons are highly experienced in treating rare bone cancers like chondrosarcoma. Specialized oncology centers utilize multidisciplinary tumor boards and advanced limb-sparing techniques. Leading specialists often hold international certifications and have performed over 1,000 bone tumor surgeries in JCI-accredited facilities.
Bookimed Expert Insight: While many hospitals treat general cancers, chondrosarcoma requires specific orthopedic oncology expertise. Anadolu Medical Center stands out because its affiliation with Johns Hopkins Medicine provides access to global protocols. Their specialists, like Prof. Dr. Bulent Karagoz, combine 20+ years of experience with tumor biology research, which is crucial for managing rare, chemo-resistant bone tumors.
Patient Consensus: Patients note it's important to find a dedicated sarcoma specialist rather than a general surgeon. They emphasize that while top-tier clinic services are excellent, costs for these specialized rare cancer treatments can be high.
Turkey is a safe, high-authority destination for oncology. International patients access JCI-accredited facilities with survival rates exceeding 86% for specific cancers. Leading centers like Anadolu Medical Center maintain affiliations with Johns Hopkins Medicine. This ensures strict adherence to North American clinical safety protocols.
Bookimed Expert Insight: While many choose hospitals based on brand names, safety in chondrosarcoma treatment depends on orthopedic oncology specialization. Dr. Mehmet Taner Ozdemir at Anadolu Medical Center trained at the Hospital for Special Surgery in New York. This specific expertise in bone-and-soft-tissue surgery is rare and offers better safety than general oncology departments.
Patient Consensus: Patients note it is important to confirm a multidisciplinary team handles the case. They also recommend getting a second pathology review before starting treatment.
Turkey provides structured follow-up and rehabilitation including oncology surveillance and specialized physical therapy. Post-operative care integrates scheduled imaging, wound management, and gait training. Joint Commission International (JCI) accredited centers like Anadolu Medical Center employ multidisciplinary tumor boards to monitor long-term recovery and recurrence.
Bookimed Expert Insight: Turkish oncology centers often use multidisciplinary tumor boards even during the follow-up phase. Since medical oncologists like Dr. Yesim Yildirim and Dr. Bulent Karagoz work in the same facilities, patients receive coordinated care. This ensures that any imaging results are reviewed by both surgeons and oncologists immediately.
Patient Consensus: Patients note that while surgery is the primary focus, the intensity of physical therapy varies by clinic. Many emphasize the importance of following strict weight-bearing restrictions while waiting for clear pathology results.
International patients typically start chondrosarcoma treatment in Turkey within 1 to 2 weeks of contact. JCI-accredited centers often provide preliminary plans within 3 business days of reviewing imaging. Specialized surgeons at hospitals like Anadolu Medical Center or Medipol Mega initiate procedures swiftly after arrival.
Bookimed Expert Insight: Our data shows clinics like Anadolu Medical Center serve 65,000 patients annually despite higher-than-average costs. Patients choose these centers for their affiliation with Johns Hopkins and specific sarcoma surgeons like Dr. Mehmet Taner Ozdemir. If you have your DICOM scans ready, these high-volume centers can shave 4 days off your waiting period.
Patient Consensus: Patients note that having translated pathology notes and original imaging ready is vital for a fast start. They emphasize that while speed is important, ensuring a correct pathology re-read by Turkish experts avoids errors in surgical planning.
Top Turkish hospitals for chondrosarcoma include JCI-accredited centers like Anadolu Medical Center, Hisar Hospital Intercontinental, and Memorial Şişli. These facilities offer specialized orthopedic oncology, utilizing advanced bone resection and reconstruction. Expert teams include ESMO-certified oncologists and surgeons affiliated with Johns Hopkins.
Bookimed Expert Insight: Our data shows Memorial Health Group hospitals offer specialized chest wall reconstruction packages starting around $17,400. This is significant because chondrosarcoma often requires specialized rib or sternum resection. Clinics like Memorial Göztepe include preoperative tests and expert consultations within these surgical bundles, ensuring all-in-one care for complex bone cancer cases.
Patient Consensus: Patients note it is important to choose hospitals with multidisciplinary tumor boards where oncologists and orthopedic surgeons collaborate. Many find the shorter waiting times for specialized scans and surgery in Istanbul helpful for fast treatment.
Turkish surgeons are highly experienced in treating chondrosarcoma. Specialists often hold 20+ years of oncology experience. Major centres in Istanbul and Ankara perform complex tumour resections and limb-salvage surgeries. These facilities use JCI-accredited protocols and imaging to manage rare bone sarcomas.
Bookimed Expert Insight: Turkish orthopaedic oncologists often hold memberships in the European Musculoskeletal Tumor Society. Dr Mehmet Taner Ozdemir is an example. This connection is vital because chondrosarcoma requires highly specific surgical margins. Data shows these specialists often complete fellowships at top-tier US institutions. They bring surgical techniques to Istanbul's JCI-accredited hospitals.
Patient Consensus: Patients report high satisfaction with the medical service and clinical results at major Istanbul centres. Some note that costs at premier clinics are significant. However, they value the professional support and high-quality care received in Turkey.
Turkey is a high-quality destination for chondrosarcoma treatment. This is due to its JCI-accredited oncology centres and multidisciplinary expert teams. Specialist surgeons perform complex bone resections, while oncologists provide targeted therapies and specialised radiation. Patients typically access surgical treatment within 1–2 weeks.
Bookimed Expert Insight: While many patients focus on surgery, the standard of follow-up care distinguishes top Turkish centres. Facilities like Anadolu Medical Center maintain a formal affiliation with Johns Hopkins Hospital. This means their sarcoma protocols align with American clinical standards. This is particularly valuable for chondrosarcoma cases. These require precise imaging to monitor for local recurrence over several years.
Patient Consensus: Patients are generally satisfied with the oncology services and technical results in Turkey. They often note that complex diagnostics are handled efficiently. However, they suggest confirming all inclusions in treatment plans before arrival.
Surgical resection is the primary treatment for chondrosarcoma in Turkey. Specialists focus on removing the tumour with clean margins. This approach is essential because these bone cancers are typically resistant to traditional chemotherapy and radiation. Specialised centres often use limb-sparing techniques.
Bookimed Expert Insight: Turkish oncology centres like Anadolu Medical Center are directly affiliated with Johns Hopkins Hospital. This allows surgeons to use US-standard multidisciplinary tumour boards for rare bone sarcomas. Patients benefit from American-level treatment protocols at Turkish price points. These price points often include preoperative tests and consultations.
Patient Consensus: Patients note that while treatment results are successful, costs vary significantly across Istanbul clinics. Many highlight that a personal coordinator helps manage the logistics of sarcoma surgery in Turkey.